Atlas Trials

Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy

Clinical trial NCT03352076 · COMPLETED

Trial details

NCT number
NCT03352076
Sponsor
Viramal Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometriosis
Start date
2017-12-28
Primary completion
2019-10-24
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.